TB-500
Thymosin Beta-4 Fragment — Research Grade
"A thymosin-derived actin-binding peptide fragment for tissue biology research."
TB-500 is a synthetic fragment of thymosin beta-4 (LKKTETQ sequence) supplied for in vitro and laboratory research use only. Researchers use it to study actin regulation, cell migration mechanisms, angiogenesis, and tissue repair pathway biology in controlled experimental settings. Not for human or veterinary use.
Contact our research team to discuss purity specifications, available quantities, certificate of analysis, and shipping requirements for your laboratory.
For in vitro laboratory research use only. Not for human or veterinary consumption. A Certificate of Analysis (CoA) is provided with every order.
How It Works
In research settings, TB-500 is studied for its interactions with actin-binding pathways, cell migration signaling, and angiogenic processes. As the active fragment of thymosin beta-4, it enables targeted investigation of specific actin-regulatory mechanisms relevant to wound healing and tissue regeneration biology.
Observed Research Endpoints
- Enables targeted actin-binding pathway research
- Supports cell migration and wound healing biology studies
- Useful for angiogenesis mechanism research models
- Active fragment design allows targeted pathway investigation
- Valuable reference compound in regenerative biology research
Important Considerations
- For laboratory research use only — not for human or veterinary consumption
- Handle according to institutional biosafety protocols
- Store under recommended conditions to maintain peptide integrity
- Requires qualified research personnel and appropriate laboratory facilities
- Dispose of in accordance with institutional waste management guidelines
Supplied as a research-grade peptide for in vitro laboratory use only. Not intended or suitable for administration to humans or animals. All research must comply with applicable institutional and regulatory requirements.